Long COVID-related fatigue linked to anxiety and depression

Credit: CC0 Public Domain

Scientists from the Universitat Oberta de Catalunya found that fatigue in long COVID patients is related to anxiety, depression and apathy.

The research is published in the Journal of Neurology and was conducted by Marco Calabria et al.

The most common symptoms of the post-COVID-19 condition known as long COVID include fatigue, shortness of breath and cognitive dysfunction.

Previous research has found that the disease had a generalized impact on attention skills, executive functions, learning and long-term memory.

Furthermore, between 9% and 49% of patients present fatigue four weeks after the onset of symptoms, and it may even persist for a year in at least a third of patients.

In the study, the team examined 136 patients with COVID-19 who were suffering from cognitive deficits eight months after contracting the virus.

Fatigue is characterized by excessive tiredness and physical and/or cognitive and muscular weakness.

According to the researchers, the results of the study highlight the importance of a holistic approach when evaluating and considering a potential treatment for COVID-19 patients experiencing fatigue.

However, there are still many unanswered questions.

How these changes are reflected at the brain level, how long they last, who’s more likely to suffer from these symptoms for a long time, and what the individual characteristics that predict recovery are.

The team says persistent fatigue is very disabling and greatly limits people’s quality of life.

If someone suffers from fatigue as a result of COVID-19, it’s important to study this situation in further depth and to determine what other symptoms or disorders are linked to this condition.

If you care about Long COVID, please read studies that lung damage may persist long after COVID-19 infection, and doctors explain the mystery of long COVID.

For more information about COVID, please see recent studies that many people with long COVID get memory problems, and results showing this drug may relieve painful ‘long covid’ symptoms.

Copyright © 2022 Knowridge Science Report. All rights reserved.